ISTAART Voices (CME, CNE)

Activity Available: April 2024 – April 2026

Education Activity Description: Listen to ISTAART voices, a new offering from the Alzheimer’s Association the International Society to Advance Alzheimer Research and Treatment (ISTAART). ISTAART Voices navigates the intricate world of dementia research and treatment in conversation with the researchers who are shaping the field.

Jointly provided by Postgraduate Institute for Medicine and Alzheimer’s Association

Estimated time to complete activity:  Approximately 30 minutes per episode (.25 Credits)

Learning Objectives:

Episode 1

Discuss the link between culture and health
Discuss strategies to address and eliminate underrepresentation of minorities in research
Understand the current data regarding underrepresentation of minorities in dementia care research

Episode 2

Discuss inflammation as a key driver of sporadic Alzheimer's disease
Discuss the impact of GCPII inhibition is a novel strategy to help prevent tau pathology at early stages
Understand GCPII inflammatory signaling in brain decreases mGluR3 regulation of calcium

Faculty Disclosure Information

Episode 1: Sharon Sanz Simon, PhD, Neuropsychologist, Associate Research Scientist at Cognitive Neuroscience Division, Taub Institute, Columbia University Irving Medical Center has nothing to disclose

Episode 2: Shveta Bathla, PhD, Psychiatry Department,Yale/ NIDA Neuroproteomics Center Yale school of medicine as nothing to disclose

Accreditation Information

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Target Audience:   This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.

Statement of Purpose: A practice gap is the difference between what healthcare professionals should or could be doing and what they are currently doing. Using current evidence based to bridge the gap between patient care and care recommendation, ensuring healthcare professionals are not only aware of current practice but are utilizing them in patient care settings. This will be accomplished by increasing competence and knowledge through (1) providing strategies to engage underserved communities in research; (2) discussing how Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques might have an impact on cognition; and (3) exploring the link between community disadvantage and cognitive decline and providing strategies to engage underserved communities in research.

Joint Accreditation

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Alzheimer's Association.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designations:

Physician Continuing Medical Education; The Postgraduate Institute for Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™ per episode. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is .25 contact hours per episode. This activity is being presented without bias and without commercial support.

Credit Claiming Instructions:

Login or Create a New Account (will take less than 1 minute)  https://www.cmeuniversity.com/

If you receive a message when creating a new account that “the email you entered is already in use”, please click the forgot my username or password link to have your Username and Password sent to you via email

After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page

Below are direct links to claim credit for each specific podcast episode:

Episode 1:The Hidden Realities of Dementia in Underrepresented Communities https://www.cmeuniversity.com/course/take/124774

For additional questions please contact clinical education staff at clinicaledu@alz.org